Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - UNIGENE LABORATORIES INCFinancial_Report.xls
EX-31.1 - EXHIBIT 31.1 - UNIGENE LABORATORIES INCex31-1.htm
EX-32.2 - EXHIBIT 32.2 - UNIGENE LABORATORIES INCex32-2.htm
EX-10.4 - EXHIBIT 10.4 - UNIGENE LABORATORIES INCex10-4.htm
EX-10.2 - EXHIBIT 10.2 - UNIGENE LABORATORIES INCex10-2.htm
EX-31.2 - EXHIBIT 31.2 - UNIGENE LABORATORIES INCex31-2.htm
EX-10.3 - EXHIBIT 10.3 - UNIGENE LABORATORIES INCex10-3.htm
EX-10.1 - EXHIBIT 10.1 - UNIGENE LABORATORIES INCex10-1.htm
10-Q - FORM 10Q - UNIGENE LABORATORIES INCunge_10q-093011.htm
Exhibit 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
 
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of Unigene Laboratories, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ashleigh Palmer, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)           the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)           the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
/s/Ashleigh Palmer
Ashleigh Palmer
Chief Executive Officer
November 9, 2011